By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 81.70 |
Change Today | -0.33 |
% Change | -0.41 % |
52 Week High | 109.62 |
52 Week Low | 78.84 |
Volume | 345,954 |
Shares Issued | 1,256.00m |
Market Cap | 102,610m |
Beta | 0.74 |
Strong Buy | 13 |
Buy | 6 |
Neutral | 8 |
Sell | 0 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
13:16 | 171 @ 81.70 |
13:16 | 142 @ 81.70 |
13:16 | 60 @ 81.71 |
13:16 | 17 @ 81.71 |
13:16 | 18 @ 81.71 |
You are here: research